|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.727
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.676
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.652
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.613
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.552
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.521
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.503
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.503
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.490
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.432
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.363
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.354
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.351
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.295
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.277
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.269
|
Zebrafish |
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.268
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.242
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.239
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.237
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.233
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.228
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.222
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.220
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.213
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.212
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.208
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.208
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.206
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.198
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.198
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.197
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.194
|
Mouse |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.189
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.189
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.189
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.184
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.178
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.175
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.174
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.174
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.169
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.168
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.168
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.165
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.157
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.151
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.147
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.144
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.144
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.143
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.142
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.141
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.141
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.140
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.139
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.136
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.136
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.135
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.134
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.134
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.133
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.133
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.130
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.129
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.128
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.127
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.126
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.125
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.122
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.121
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.120
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.120
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.117
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.117
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.117
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.117
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.113
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.112
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.110
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.110
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.109
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.109
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.109
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.109
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.107
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.105
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.105
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.105
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.104
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.104
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.103
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.103
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.101
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.101
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.101
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.100
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.099
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.098
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.098
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.097
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.096
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.096
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.096
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.096
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.093
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.092
|
|
|
|
axonal fasciculation
|
GO:0007413 |
15 |
0.092
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.091
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.091
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.090
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.090
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.089
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.089
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.088
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.087
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.087
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.085
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.085
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.084
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.084
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.083
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.083
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.082
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.082
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.081
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.081
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.081
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.080
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.080
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.080
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.079
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.078
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.078
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.078
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.076
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.076
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.076
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.075
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.075
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.075
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.074
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.074
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.074
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.073
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.073
|
Zebrafish |
|
|
lipid modification
|
GO:0030258 |
65 |
0.072
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.072
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.072
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.071
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.071
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.071
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.070
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.070
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.070
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.070
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.070
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.069
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.068
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.068
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.066
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.066
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.063
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.062
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.062
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.061
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.061
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.060
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.060
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.060
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.060
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.059
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.059
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.059
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.059
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.059
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.058
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.058
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.058
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.057
|
Zebrafish |
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.056
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.056
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.056
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.056
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.056
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.056
|
Zebrafish |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.055
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.055
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.055
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.055
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.055
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.054
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.054
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.054
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.054
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.054
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.054
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.054
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.053
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.053
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.052
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.052
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.052
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.052
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.051
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.051
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.051
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.051
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.051
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.050
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.050
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.050
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.050
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.049
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.049
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.048
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.048
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.048
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.048
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.048
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.047
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.047
|
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
11 |
0.047
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.047
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.047
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.046
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.046
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.046
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.046
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.046
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.046
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.045
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.045
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.045
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.045
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.044
|
Zebrafish |
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.044
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.044
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.044
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.044
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.044
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.043
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.043
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.043
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.043
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.043
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.042
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.042
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.042
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.042
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.042
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.042
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.042
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.041
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.041
|
Zebrafish |
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.041
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.040
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.040
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.040
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.040
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.040
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.040
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.040
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.040
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.040
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.039
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.039
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.039
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.039
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.038
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.038
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.038
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.038
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.038
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.038
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.037
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.037
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.037
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.036
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.036
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.035
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.035
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.035
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.035
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.035
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.035
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.035
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.035
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.034
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.034
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.034
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.034
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.033
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.033
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.033
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.033
|
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.032
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.032
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.032
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.032
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.032
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.032
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.031
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.031
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.031
|
|
|
|
cellular response to lithium ion
|
GO:0071285 |
10 |
0.031
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.031
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.031
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.030
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.030
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.030
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.030
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.030
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.030
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.030
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.030
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.030
|
Zebrafish |
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.029
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.029
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.029
|
|
|
|
hematopoietic stem cell proliferation
|
GO:0071425 |
13 |
0.029
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.029
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.029
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.029
|
|
|
|
regulation of granulocyte differentiation
|
GO:0030852 |
8 |
0.029
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.028
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.028
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.028
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.028
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.028
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.028
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.028
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.027
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.027
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.027
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.027
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.027
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.027
|
Zebrafish |
|
|
cartilage development
|
GO:0051216 |
140 |
0.027
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.027
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.027
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.027
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.027
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.027
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.027
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.027
|
Zebrafish |
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.026
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
Zebrafish |
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.026
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.026
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.026
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.026
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.025
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.025
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.025
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.025
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.025
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.025
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.025
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.024
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.024
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.024
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.024
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.024
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.024
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.024
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.024
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.024
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.024
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.024
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.024
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.023
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.023
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.023
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.023
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.023
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.023
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.023
|
|
|
|
phospholipid homeostasis
|
GO:0055091 |
6 |
0.023
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.023
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.022
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.022
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.022
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.022
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.022
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.022
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.022
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.022
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.022
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.022
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.022
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.022
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.022
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.022
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.022
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.022
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.022
|
|
|
|
regulation of alcohol biosynthetic process
|
GO:1902930 |
16 |
0.022
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.021
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.021
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.021
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.021
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.021
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.021
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.021
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.021
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.021
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.021
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.021
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.021
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.021
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.021
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.021
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.020
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.020
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.020
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.020
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.020
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.020
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.020
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.020
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.020
|
|
|
|
negative regulation of protein localization to nucleus
|
GO:1900181 |
23 |
0.020
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.020
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.020
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.019
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.019
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.019
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.019
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.019
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.019
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.019
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.019
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.019
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.019
|
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.019
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.019
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.019
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.019
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.019
|
|
|
|
neuron recognition
|
GO:0008038 |
25 |
0.019
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.018
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.018
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.018
|
Zebrafish |
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.018
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.018
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.018
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.018
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.018
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.018
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.018
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.018
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.018
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.018
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.018
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.018
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.018
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.018
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.018
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.018
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.018
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.018
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.018
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.018
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.018
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.018
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.018
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.018
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.017
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.017
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.017
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.017
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.017
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.017
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.017
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.017
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.017
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.017
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.017
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.017
|
|
